Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes Sr. VP & CSO gave up 953 shares (to pay taxes)
  2. 4 Shares withheld for taxes Treasurer and CFO gave up 958 shares (to pay taxes)
  3. 4 Shares withheld for taxes President and CEO gave up 2,355 shares (to pay taxes)
  4. 4 Option exercise President and CEO acquired 10,063 shares (option exercise)
  5. 4 Open-market sale Sr. VP & Chief Medical Officer sold 12,536 shares at $70.13 ($879,150)
  6. 4 Shares withheld for taxes Sr. VP & General Counsel gave up 557 shares (to pay taxes)
  7. 4 Open-market sale Sr. VP & Chief Medical Officer sold 13,523 shares at an average $86.35 ($1,167,690)
  8. 4 Shares withheld for taxes Sr. VP & CSO gave up 557 shares (to pay taxes)
  9. 4 Shares withheld for taxes Treasurer and CFO gave up 557 shares (to pay taxes)
  10. 4 Shares withheld for taxes President and CEO gave up 1,944 shares (to pay taxes)
  11. 4 Grant or award Sr. VP, Business Dev. acquired 6,800 shares (grant or award)
  12. 4 Grant or award Sr. VP, New Product Dev. acquired 6,800 shares (grant or award)
  13. 4 Grant or award Sr. VP & General Counsel acquired 6,800 shares (grant or award)
  14. 4 Grant or award Sr. VP & Chief Medical Officer acquired 6,800 shares (grant or award)
  15. 4 Grant or award Sr. VP & CSO acquired 6,800 shares (grant or award)
  16. 4 Grant or award Treasurer and CFO acquired 6,800 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 25,700 shares (grant or award)
  18. 4 Open-market sale Sr. VP & Chief Medical Officer sold 9,547 shares at an average $84.89 ($810,419)
  19. 4 Open-market sale Sr. VP & Chief Medical Officer sold 17,500 shares at an average $70.15 ($1,227,620)
  20. 4 Open-market sale President and CEO sold 4,516 shares at $59.06 ($266,698)

Page 9 of 24 · 475 filings